WO2002027329A3 - Biomarqueurs du carcinome transitionnel de la vessie - Google Patents
Biomarqueurs du carcinome transitionnel de la vessie Download PDFInfo
- Publication number
- WO2002027329A3 WO2002027329A3 PCT/US2001/029657 US0129657W WO0227329A3 WO 2002027329 A3 WO2002027329 A3 WO 2002027329A3 US 0129657 W US0129657 W US 0129657W WO 0227329 A3 WO0227329 A3 WO 0227329A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bladder
- cell carcinoma
- transitional cell
- biomarkers
- tcc
- Prior art date
Links
- 206010044412 transitional cell carcinoma Diseases 0.000 title abstract 2
- 239000000090 biomarker Substances 0.000 title 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01973369A EP1354203B1 (fr) | 2000-09-25 | 2001-09-21 | Biomarqueurs du carcinome transitionnel de la vessie |
US10/381,369 US20040043436A1 (en) | 2001-09-21 | 2001-09-21 | Biomarkers of transitional cell carcinoma of the bladder |
JP2002530857A JP2004525343A (ja) | 2000-09-25 | 2001-09-21 | 膀胱の移行上皮癌の生物マーカー |
AU2001292958A AU2001292958A1 (en) | 2000-09-25 | 2001-09-21 | Biomarkers of transitional cell carcinoma of the bladder |
DE60128487T DE60128487T2 (de) | 2000-09-25 | 2001-09-21 | Biomarkierungen des übergangszellkarzinoms der blase |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23523800P | 2000-09-25 | 2000-09-25 | |
CA002320549A CA2320549A1 (fr) | 2000-09-25 | 2000-09-25 | Biomarqueurs de carcinome transitionnel de la vessie |
US60/235,238 | 2000-09-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002027329A2 WO2002027329A2 (fr) | 2002-04-04 |
WO2002027329A3 true WO2002027329A3 (fr) | 2003-08-07 |
Family
ID=25682105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/029657 WO2002027329A2 (fr) | 2000-09-25 | 2001-09-21 | Biomarqueurs du carcinome transitionnel de la vessie |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001292958A1 (fr) |
CA (1) | CA2320549A1 (fr) |
WO (1) | WO2002027329A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7217515B2 (en) | 2002-09-30 | 2007-05-15 | Chi Mei Foundation Medical Center | HURP gene as a molecular marker for bladder cancer |
EP1895302A3 (fr) * | 2003-04-08 | 2008-05-14 | Colotech A/S | Procédé de détection d'un cancer colorectal dans des prélèvements humains |
US7425700B2 (en) | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
BR122020001099B1 (pt) * | 2004-07-23 | 2021-12-14 | Pacific Edge Biotechnology Ltd | Processos para a detecção de câncer de bexiga em indivíduos |
EP1784499A4 (fr) * | 2004-07-23 | 2007-08-22 | Eastern Virginia Med School | Biomarqueurs du cancer de la vessie |
NZ545243A (en) * | 2006-02-10 | 2009-07-31 | Pacific Edge Biotechnology Ltd | Urine gene expression ratios for detection of cancer |
IL303893A (en) | 2019-08-05 | 2023-08-01 | Seer Inc | Systems and methods for sample preparation, data generation, and protein corona analysis |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5500347A (en) * | 1990-07-27 | 1996-03-19 | Progen Biotechnik Gmbh | Method for the purification of cytokeratin 20 and its use for the production of antibodies |
WO1998059360A1 (fr) * | 1997-06-20 | 1998-12-30 | Ciphergen Biosystems, Inc. | Chromatographie par retentat et ensembles de detection de proteines ayant des applications en biologie et en medecine |
WO2000019208A1 (fr) * | 1998-09-30 | 2000-04-06 | University Of Ulster At Jordanstown | Fragment de 37 kda d'egfr (recepteur du facteur de croissance epidermique) utile comme marqueur de cancer |
WO2000029987A1 (fr) * | 1998-11-17 | 2000-05-25 | University Of Maryland | Procedes servant a identifier et a classifier des organismes par spectrometrie de masse et recherche dans une base de donnees |
WO2001036977A2 (fr) * | 1999-11-16 | 2001-05-25 | Matritech, Inc. | Procedes et compositions d'identification de marqueurs de maladie |
WO2001071360A2 (fr) * | 2000-03-20 | 2001-09-27 | Eastern Virginia Medical School | Marqueurs du cancer de la prostate |
-
2000
- 2000-09-25 CA CA002320549A patent/CA2320549A1/fr not_active Abandoned
-
2001
- 2001-09-21 AU AU2001292958A patent/AU2001292958A1/en not_active Abandoned
- 2001-09-21 WO PCT/US2001/029657 patent/WO2002027329A2/fr active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5500347A (en) * | 1990-07-27 | 1996-03-19 | Progen Biotechnik Gmbh | Method for the purification of cytokeratin 20 and its use for the production of antibodies |
WO1998059360A1 (fr) * | 1997-06-20 | 1998-12-30 | Ciphergen Biosystems, Inc. | Chromatographie par retentat et ensembles de detection de proteines ayant des applications en biologie et en medecine |
WO2000019208A1 (fr) * | 1998-09-30 | 2000-04-06 | University Of Ulster At Jordanstown | Fragment de 37 kda d'egfr (recepteur du facteur de croissance epidermique) utile comme marqueur de cancer |
WO2000029987A1 (fr) * | 1998-11-17 | 2000-05-25 | University Of Maryland | Procedes servant a identifier et a classifier des organismes par spectrometrie de masse et recherche dans une base de donnees |
WO2001036977A2 (fr) * | 1999-11-16 | 2001-05-25 | Matritech, Inc. | Procedes et compositions d'identification de marqueurs de maladie |
WO2001071360A2 (fr) * | 2000-03-20 | 2001-09-27 | Eastern Virginia Medical School | Marqueurs du cancer de la prostate |
Non-Patent Citations (2)
Title |
---|
A. VLAHOU ET AL: "Development of a novel proteomic approach for the detection of transitional cell carcinome of the bladder in urine", AMERICAN JOURNAL OF PATHOLOGY, vol. 158, no. 4, 1 April 2001 (2001-04-01), pages 1491 - 1502, XP002201552 * |
RASMUSSEN H H ET AL: "TOWARDS A COMPREHENSIVE DATABASE OF PROTEINS FROM THE URINE OF PATIENTS WITH BLADDER CANCER", JOURNAL OF UROLOGY, BALTIMORE, MD, US, vol. 155, no. 6, June 1996 (1996-06-01), pages 2113 - 2119, XP001006003, ISSN: 0022-5347 * |
Also Published As
Publication number | Publication date |
---|---|
CA2320549A1 (fr) | 2002-03-25 |
WO2002027329A2 (fr) | 2002-04-04 |
AU2001292958A1 (en) | 2002-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003008933A3 (fr) | Bande d'essai pour dosage a ecoulement lateral d'un echantillon renfermant des cellules entieres | |
WO2002077604A3 (fr) | Cellules marquees servant de temoin fonctionnel interne dans des essais de detection de cellules rares | |
MXPA02011479A (es) | Composiciones reactivas estabilizadas de tetrazolio y metodos para usar las mismas. | |
WO2005010213A3 (fr) | Marqueurs pour la detection du cancer de l'estomac | |
WO2006137932A3 (fr) | Detection homogene de substance a analyser | |
WO1999042821A3 (fr) | Traitement du cancer | |
WO2006026601A3 (fr) | Dosage immunologique enzymatique homogene pour un fluide buccal | |
WO2007030949A3 (fr) | Procedes de diagnostic de cancer des ovaires et necessaires a cet effet | |
WO2001025791A3 (fr) | Proteines marqueur du cancer de la prostate | |
WO2003033731A3 (fr) | Methodes de detection du cancer de l'ovaire | |
CA2510377A1 (fr) | Utilisation de la nicotinamide n-methyltransferase comme marqueur du cancer colorectal | |
WO2007111875A3 (fr) | Procedes de diagnostic et de traitement du cancer des reins et du cancer colo-rectal | |
WO2003050291A3 (fr) | Capteurs utilises dans le test d'echantillons biologiques chimiques ou environnementaux | |
WO2001055719A3 (fr) | Kit de diagnostic permettant de detecter des niveaux de creatine | |
WO2002027329A3 (fr) | Biomarqueurs du carcinome transitionnel de la vessie | |
AU7410600A (en) | Method for the determination of substances using the evanescence field method | |
TW200739073A (en) | Test sensor reagent having cellulose polymers | |
WO2002023200A3 (fr) | Biomarqueurs humains du cancer du sein | |
WO2001092877A3 (fr) | Procede d'identification et/ou d'isolement de cellules souches et d'etablissement de pronostic sur la sensibilite au traitement de leucemie | |
WO2003084384A3 (fr) | Diagnostic de l'infection a flavivirus | |
CA2407760A1 (fr) | Methodes pour le diagnostic de l'astrocytome de bas grade | |
WO2002097439A3 (fr) | Procede d'etiquetage differentiel | |
DE69730327D1 (de) | Marker für unfruchtbarkeit und/oder -fruchtbarkeit bei männern | |
WO2003058198A3 (fr) | Biomarqueurs du cancer du sein humain | |
SI1565490T1 (sl) | Partnerji vezave holo transkobalaminov in njihovauporaba v kobalaminskem testu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002530857 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001973369 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10381369 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2001973369 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001973369 Country of ref document: EP |